Eurofins Scientific Shares Dip Below €67.50 Midday
Eurofins Scientific shares are consolidating this Monday, February 9, 2026, midday, dropping 1.12% to €67.24. The analytical and certification genius's stock thus gives up some of the gains accumulated in recent weeks, after a year-over-year increase of 31.84%. This adjustment phase occurs as the stock trades above its structuring moving averages.
Technical Analysis Overview
The graphical analysis of Eurofins Scientific reveals an intermediate positioning of the price, which remains above its 50-day moving average set at €64.58, as well as its 200-session average at €62.07. This configuration remains generally favorable, although the stock is distant from its 20-day moving average set at €70.22. Regarding oscillators, the relative strength index is at 36 points, indicating a short-term bearish trend without reaching an extreme oversold zone. This reading is in a context of monthly volatility measured at 9.21%, reflecting moderate fluctuations for this specialist in analytical testing and laboratory services.
Recent Performance Context
The decline observed this Monday follows a notable bullish sequence, with a quarterly increase of 15.37% and an advance of more than 31% over twelve months. This performance reflects a renewed interest from investors in the Luxembourg-based global leader in bioanalysis, which has faced operational challenges in some divisions in recent years. The current valuation places the stock in an intermediate zone between its technical support identified at €61.62 and resistance at €73.12. Thus, today's corrective movement appears more as a breathing phase rather than a major reversal, with the price remaining well above its previous lows. The group's trajectory will largely depend on its ability to maintain organic growth and consolidate margins in a demanding competitive environment.
